Euro GTP Guidance - Euro GTPs
Euro GTP Guidance - Euro GTPs
Euro GTP Guidance - Euro GTPs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A.2.3. FACILITIES, EQUIPMENT AND MATERIALS FOR STORING<br />
1. The devices intended for storage should be located preferably in a separate area to which<br />
access is controlled and restricted to authorized persons.<br />
2. A temperature monitoring system should be utilized to document temperatures and to alert<br />
staff when temperatures have strayed outside acceptable limits. Procedures should be in<br />
place for reviewing temperatures. If storage utilizes liquid nitrogen, either liquid nitrogen<br />
levels or temperature should be monitored and documented at an interval specified in the<br />
SOP.<br />
A.3. DONOR SCREENING<br />
1. Both generic and specific <strong>GTP</strong>s should include requirements related to donor selection and<br />
evaluation, risk assessment, validation methodologies, documentation, premises, personnel<br />
and quality management.<br />
2. The major objective of the chapter on the donor screening process is to protect the final<br />
tissue recipient. Safety and quality of the human tissue depends, to a large extent, on the<br />
ability to identify true positive risks and avoid false positive risks.<br />
3. According to EU Directive 2006/17/EC, Articles 3 and 4 ‘Selection criteria for donors are<br />
based on an analysis of the risks related to the application of the specific cells/tissues.<br />
Indicators of these risks should be identified by physical examination, review of the medical<br />
and behavioural history, biological testing, post-mortem examination (for deceased donors)<br />
and any other appropriate investigation.’ Outlines for physical examination are described<br />
elsewhere in this Guide, whereas the other criteria could be defined as the process of donor<br />
screening. The purpose of screening a donor is to collect information, to assess the data on<br />
critical points of safety, quality and unique identification, and to evaluate this information in<br />
relation to relevant aspects of the tissue, in order to determine whether or not to release<br />
tissues for transplantation purposes<br />
4. This chapter aims to provide tools to carry out the screening test in the best way so as to<br />
ensure the quality of the tissue and the safety of transplant recipients. The scope of this<br />
chapter covers the steps between donor detection and donor release for further processing.<br />
A.3.1. ACTIVITIES<br />
A.3.1.1. Donor detection<br />
24